Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline

Author:

Vanderpuye Verna D.1ORCID,Clemenceau Jean Rene V.2,Temin Sarah3ORCID,Aziz Zeba4ORCID,Burke William M.5,Cevallos Nixon Leonardo6,Chuang Linus T.7,Colgan Terence J.8,del Carmen Marcela G.9,Fujiwara Keiichi10ORCID,Kohn Elise C.11,Gonzáles Nogales Jose Enrique12,Konney Thomas Okpoti13,Mukhopadhyay Asima1415,Paudel Bishnu D.16ORCID,Tóth Icó17,Wilailak Sarikapan18,Ghebre Rahel G.1920ORCID

Affiliation:

1. Korlebu Teaching Hospital, Accra, Ghana

2. Hospital Angeles Del Pedregal, Mexico City, Mexico

3. American Society of Clinical Oncology, Alexandria, VA

4. Hameed Latif Hospital, Lahore, Pakistan

5. Stony Brook University Hospital, Stony Brook, NY

6. Sociedad Lucha Contra Cancer Ecuador, Machala, Ecuador

7. Nuvance Health System, Danbury, CT

8. National Cancer Institute, Bethesda, MD

9. LifeLabs, Ontario, Canada

10. Massachusetts General Hospital, Boston, MA

11. Saitama Medical University International Medical Center, Saitama, Japan

12. Instituto Nacional de Cancerología, La Paz, Bolivia

13. Komfo Anokye Teaching Hospital, Kumasi, Ghana

14. Chittaranjan National Cancer Institute, Kolkata, India

15. Northern Gynaecological Oncology Centre, Gateshead, Newcastle, United Kingdom

16. NAMS, Bir Hospital, Kathmandu, Nepal

17. Mallow Flower Foundation, Dunaharaszti, Hungary

18. Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

19. University of Minnesota Medical School, Minneapolis, MN

20. St Paul's Hospital Millennium Medical School, Addis Ababa, Ethiopia

Abstract

PURPOSE To provide expert guidance to clinicians and policymakers in three resource-constrained settings on diagnosis and staging of adult women with ovarian masses and treatment of patients with epithelial ovarian (including fallopian tube and primary peritoneal) cancer. METHODS A multidisciplinary, multinational ASCO Expert Panel reviewed existing guidelines, conducted a modified ADAPTE process, and conducted a formal consensus process with additional experts. RESULTS Existing sets of guidelines from eight guideline developers were found and reviewed for resource-constrained settings; adapted recommendations from nine guidelines form the evidence base, informing two rounds of formal consensus; and all recommendations received ≥ 75% agreement. RECOMMENDATIONS Evaluation of adult symptomatic women in all settings includes symptom assessment, family history, and ultrasound and cancer antigen 125 serum tumor marker levels where feasible. In limited and enhanced settings, additional imaging may be requested. Diagnosis, staging, and/or treatment involves surgery. Presurgical workup of every suspected ovarian cancer requires a metastatic workup. Only trained clinicians with logistical support should perform surgical staging; treatment requires histologic confirmation; surgical goal is staging disease and performing complete cytoreduction to no gross residual disease. In first-line therapy, platinum-based chemotherapy is recommended; in advanced stages, patients may receive neoadjuvant chemotherapy. After neoadjuvant chemotherapy, all patients should be evaluated for interval debulking surgery. Targeted therapy is not recommended in basic or limited settings. Specialized interventions are resource-dependent, for example, laparoscopy, fertility-sparing surgery, genetic testing, and targeted therapy. Multidisciplinary cancer care and palliative care should be offered. Additional information can be found at www.asco.org/resource-stratified-guidelines . It is ASCO's view that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3